ACP Journal Club. Apixaban reduced stroke or systemic embolism in AF more than warfarin regardless of type or duration of AF
- PMID: 23856706
- DOI: 10.7326/0003-4819-159-2-201307160-02008
ACP Journal Club. Apixaban reduced stroke or systemic embolism in AF more than warfarin regardless of type or duration of AF
Comment on
-
Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial.Eur Heart J. 2013 Aug;34(31):2464-71. doi: 10.1093/eurheartj/eht135. Epub 2013 Apr 17. Eur Heart J. 2013. PMID: 23594592 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical